Fuse Science Ships Over $500,000 in Orders for Quarter-End

New Post Public Reply Private Reply Replies (0) Message Board
Dago
Fuse Science Ships Over $500,000 in Orders for Quarter-End December 31st, 2013 and Takes Critical Steps to Secure Required Capital to Continue Execution of Business Model

MIAMI LAKES, FL--(Marketwired - Jan 6, 2014) - Fuse Science, Inc. (OTCQB: DROP) (www.fusescience.com), a consumer products and delivery technology company that is developing new, patent-pending technologies working to redefine how consumers receive energy, medicines, vitamins and minerals announced that it recently took further steps towards securing the additional capital to continue the ongoing execution of its business plan.
On Friday, January 3, 2014, the Company filed a Form 8-K in which Fuse announced that it had entered into a securities purchase agreement with two investors, pursuant to which Fuse agreed to issue and sell senior secured convertible notes in the aggregate original principal amount of $1,000,000, together with warrants to purchase common stock. Friday's filing can be viewed within the SEC filings section of the Fuse Science corporate web site at www.fusescience.com or at www.sec.gov.
In November 2013, the Company announced strategic investments from Muscle Pharm Inc., Phil Frost and others focused on the ongoing development of Fuse's proprietary technology and consumer products. Last Friday's investment is a further step in this effort. All strategic partners in the November 2013 round rolled their funding into the current round, moving the note terms from sixty days to a five-year maturity which allows Fuse to execute against its objectives.
This current action is the next step in a series of financial steps the Company is taking to provide for continued growth. Friday's investment of an additional $1MM in working capital consists of $550,000 funded on January 3, 2014. The $450,000 balance is expected to be funded in four (4) monthly installments of $100,000 and a final installment of $50,000.
During this time the Company will continue its efforts to advance the commercialization of its PowerFuse(R), ElectroFuse(R) and EnerJel(R) brands, leveraging its world class athletes while taking required administrative steps to ensure the next phase of business growth and funding. In November and December 2013, the Company completed production shoots and commercials with World Series MVP David Ortiz and Wimbledon Champ Andy Murray, which are center stage in the Company's advertising program. Fuse anticipates the scheduling of these productions during the first calendar quarter of 2014.
In addition, the Company reports that it shipped over $500,000 in product orders for its first quarter of fiscal year 2014, which ended December 31, 2013, which surpasses the entire previous 12 months -- illustrating optimism for continued sales growth under heavy working capital resource constraints.
Additional funding is still required to support the strategy and development of the Fuse business plan, both of which will require the authorization of additional shares to be issued. Upon shareholder approval, the Company will also execute a reverse stock split, to facilitate better structure around the market capitalization and stock price.
To become "Powered By Fuse(R)", visit your local Walgreens or Duane Reade store or go to www.poweredbyfuse.com.
About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products and delivery technology company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The Company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).
For Fuse Science news as it happens, follow @FuseScience (https://twitter.com/fuse_science) on Twitter and Like Us on Facebook at https://www.facebook.com/FuseScience!
Get all Fuse Science corporate updates sent directly to you; sign up for Fuse News Alerts here: http://ir.stockpr.com/fusescience/email-alerts.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 8

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations

Updated Category News Views 5

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 11

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 9

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 12

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 12

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 20

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 9

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 4

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 4

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading

Top 5 Most Recently Viewed Articles

Signet Jewelers Under Investigation: Important Updates for Investors

Updated Category News Views 551

Signet Jewelers Limited Investor Alert In recent developments, Signet Jewelers Limited (NYSE: SIG) is under scrutiny from the legal firm Kessler Topaz Meltzer & Check, LLP. This investigation focuses on potential violations of federal securities laws, which have raised significant concern among investors. If you are a Signet investor and experienced losses, understanding...

Continue Reading
89bio Highlights Participation at H.C. Wainwright Investor Conference

Updated Category News Views 49

89bio, Inc. announced its participation in the H. C. Wainwright 8th Annual MASH Investor Conference back in 2024, and you could almost feel traders twitching at their desks. This wasn't just another conference; it was a chance for 89bio to sell its story on pegozafermin—an engineered FGF21 analog that some think could change the game for liver and cardiometabolic...

Continue Reading
Experts See Major Potential in Upcoming Crypto Summit

Updated Category News Views 159

The Significance of the White House Crypto Summit Industry experts are eagerly anticipating the upcoming White House Crypto Summit. This critical event stands to offer pivotal regulatory clarity and establish a foundation for a strategic crypto reserve in the U.S. This summit is poised to significantly influence the future of blockchain innovation. Pivotal Alignments in...

Continue Reading
Edwards Lifesciences Faces Securities Class Action Risk

Updated Category News Views 136

Understanding the Class Action Against Edwards Lifesciences Corporation Investors in Edwards Lifesciences Corporation (NYSE: EW) recently received news regarding a potential class action lawsuit. The Rosen Law Firm is handling this investigation and is urging purchasers of the company’s securities during a specific timeframe to be aware of their rights. Who Can...

Continue Reading
Exciting Updates from Drugs Made In America Acquisition Corp.

Updated Category News Views 95

Trading Opportunities for Drugs Made In America Acquisition Corp. Holders In a significant announcement, Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) has revealed that starting on February 25, holders of the units from the company’s initial public offering (IPO) can choose to trade the company’s ordinary shares and rights separately. This move opens up new...

Continue Reading